Article thumbnail

Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation

By Martina Raudenska, Monika Kratochvilova, Tomas Vicar, Jaromir Gumulec, Jan Balvan, Hana Polanska, Jan Pribyl and Michal Masarik


Abstract We focused on the biomechanical and morphological characteristics of prostate cancer cells and their changes resulting from the effect of docetaxel, cisplatin, and long-term zinc supplementation. Cell population surviving the treatment was characterized as follows: cell stiffness was assessed by atomic force microscopy, cell motility and invasion capacity were determined by colony forming assay, wound healing assay, coherence-controlled holographic microscopy, and real-time cell analysis. Cells of metastatic origin exhibited lower height than cells derived from the primary tumour. Cell dry mass and CAV1 gene expression followed similar trends as cell stiffness. Docetaxel- and cisplatin-surviving cells had higher stiffness, and decreased motility and invasive potential as compared to non-treated cells. This effect was not observed in zinc(II)-treated cells. We presume that cell stiffness changes may represent an important overlooked effect of cisplatin-based anti-cancer drugs. Atomic force microscopy and confocal microscopy data images used in our study are available for download in the Zenodo repository (, Digital Object Identifiers:10.5281/zenodo.1494935)

Topics: Medicine, R, Science, Q
Publisher: Nature Publishing Group
Year: 2019
DOI identifier: 10.5281/zenodo.1494935).
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  •, (external link)
  • (external link)
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.